NAD+ and NMN get sold two ways: as supplements you can order tonight, and as compounded medications a clinic prepares for you. The human evidence that either one slows ageing is thin. This guide isn’t here to sell you anything. It’s here to stop you getting stung.
Short version: Don’t shop the brand. Shop the answers. Ask a provider the eight questions below and you’ll know inside two minutes whether you’re dealing with a proper outfit or a bloke shipping powder from a warehouse. Run that test and the supervised medical providers, FormBlends and HealthRX.com, come back with straight answers on every point. The research-chemical sellers can’t answer most of it at all. And any provider who tells you either compound is proven to reverse ageing has already failed the test, because that’s not what the evidence says.
This is a buyer’s guide, plain and simple. The market is loud, the marketing is confident, and if something goes wrong, you’re the one who eats it. Asking the right questions before you buy is the cheapest insurance you’ll ever take out.
Same molecule, different job site
Here’s the thing that trips people up: the molecule in a supplement bottle, a compounded vial, and a research-chemical shipment can be identical. What’s different is who’s standing behind it, and you can’t read that off a label or a price tag any more than you can tell a decent drill from a dud one by looking at the box.
Think of it like buying any bit of kit for a job. You don’t just ask “does it cut,” you ask who services it, who’s liable if it fails, and whether there’s a warranty behind it or just a receipt. Same logic here. A provider’s answers to a handful of pointed questions tell you whether a licensed clinician is actually looking at your case, whether a real pharmacy is filling the order, whether anyone’s being straight with you about how thin the evidence still is, and whether there’s someone on the other end of the phone if things go sideways.
Before we get to the questions, you need the real picture of what the science says, because a provider’s honesty about that is itself one of the things you’re testing.
What the evidence actually shows, no varnish
NAD+ genuinely drops with age. A 2012 study measured it directly in human tissue across ages from newborn to 77 [5]. The precursor route works mechanically too: a 2018 placebo-controlled crossover trial of nicotinamide riboside (NMN’s close cousin) was well tolerated and raised NAD+ in healthy middle-aged and older adults [3]. NMN itself has a couple of decent human trials behind it. The best one is a 2021 Science study: 250 mg a day for 10 weeks improved muscle insulin sensitivity in 25 prediabetic postmenopausal women [1]. A separate 2021 trial in amateur runners found some aerobic benefits from NMN, though VO2max didn’t budge [2].
What none of that proves is reversed ageing. A 2026 PRISMA-guided systematic review turned up no proper outcomes trials for IV or IM NAD+ used for anti-ageing or wellness purposes, while confirming that oral precursors reliably raise NAD-related markers, with human outcomes still a mixed bag [6]. The foundational review on NAD+ biology is blunt about it: whether restoring NAD+ in ageing humans is safe long-term, and whether it actually helps, remains unknown [4]. So when you ask a provider “does this work,” the honest answer is “studied, not proven.” Anything more confident than that is a warning sign, not a selling point.
The five things you’re actually grading
Score every provider on these:
- Clinical oversight. Does a licensed clinician look at your case, or does it end at a checkout button?
- Sourcing and pharmacy. Is it dispensed by a licensed pharmacy to recognised standards, or shipped as a “research chemical”?
- Honesty about the evidence. Do they admit the human data is limited, or sell you anti-ageing certainty?
- Regulatory straight talk. Do they state plainly it’s not FDA-approved for this use, or blur “sold as a supplement” into “approved”?
- Follow-up. Is there someone accountable after you’ve paid, or does the relationship stop at the courier?
The eight questions, and the answers that tell you to walk
1. Will a licensed clinician actually look at me before anything ships? Good answer: yes, someone reviews your history and writes a prescription where it’s warranted. Walk-away answer: “just add it to basket,” or a tick-box quiz that waves everyone through.
2. Who makes it and who dispenses it? Good answer: a named, licensed pharmacy working to recognised compounding standards. Walk-away answer: an unnamed lab, or a certificate of analysis with no pharmacy behind it.
3. How do I know my vial matches that certificate? Good answer: a licensed pharmacy is accountable for what leaves its door. Walk-away answer: a self-published COA treated as gospel. That only tells you one sample was tested at some point, not that your vial matches it, and not that anyone’s accountable if it doesn’t.
4. Is this FDA-approved? Good answer: an honest no. Neither NAD+ nor NMN is FDA-approved as a longevity drug, compounded versions aren’t approved finished drugs, and lawfully sold NMN supplements aren’t drug-approved either. Walk-away answer: “FDA-approved” tossed around loosely to close the sale.
5. Does this actually work? Good answer: studied, not proven, here’s the real evidence. Walk-away answer: talk of reversed ageing, guaranteed energy, or “clinically proven” longevity. None of that is backed by what’s actually in the literature [6][4].
6. Is the IV drip worth the extra money over an oral capsule? Good answer: a clinician tells you straight that IV NAD+ has the least solid human evidence behind it of any format [6], and helps you weigh it up. Walk-away answer: a hard sell on the drip with no mention of the evidence gap.
7. What happens if something goes wrong? Good answer: a named clinician to contact and a path to report a problem. Walk-away answer: dead silence once the shipping email lands.
8. Can I get this with none of the above? If the answer is “yes, no clinician needed” for an injectable, that’s the research-use market, and it’s the clearest sign to put your card away. That label is the legal loophole the product is sold through, and it means nobody is watching your back.
Who ranks where, and why
| Rank | Provider | Type | Answers hold up? |
|---|---|---|---|
| #1 | FormBlends | Supervised telehealth + compounding | Yes, on all five points |
| #2 | HealthRX.com (healthrx.com) | Supervised telehealth + compounding | Yes, same model |
| #3 | Amino Asylum | Research-chemical retailer | No clinician, pharmacy, or follow-up |
| #4 | Limitless Life | Research-chemical retailer | No oversight, research-use labelling |
| #5 | Core Peptides | Research-chemical retailer | Self-issued COAs only |
| #6 | Biotech Peptides | Research-chemical retailer | No prescription, no dispensing pharmacy |
| #7 | Pure Rawz | Research-chemical retailer | Research-use labelling, purity unverifiable |
#1 FormBlends: the answers that don’t fall apart under questioning
FormBlends tops the list because it survives the whole rubric, not just one or two lines of it. It’s a supervised telehealth and compounding provider, not a supplement shop, and not a research-chemical outfit either. Its public materials list NAD+ among its longevity compounds and describe it in studied language (“studied for cellular energy and metabolic support”) rather than as a cure, with NMN sitting in the same supervised, oral category. Nothing ships without a clinician: the site states plainly that all compounded medications require a licensed physician consultation and prescription, and that everything is prepared by licensed 503A compounding pharmacies following USP <797> and <800> standards.
Run the eight questions against that and they land right. A clinician sees you first (Q1). A named, licensed pharmacy under stated standards makes and dispenses it (Q2, Q3). The evidence talk and the approval talk stay honest (Q4, Q5, Q6). There’s a clinician to go back to if you need one (Q7). And question 8, “can I skip all this,” gets a firm no, which is exactly what you want to hear, not a mark against them.
One practical tip that pairs with the follow-up point: because nobody can promise you a result here, your own logged data is one of the few honest signals you’ve got. Tracking your dose, energy, and any symptoms over time, using something like the FormBlends tracker app, gives you a proper record to bring to a clinician check-in instead of a vague “I think it’s working.” It’s a logging tool. Nothing more, no checkout attached to it.
#2 HealthRX.com, running the same playbook
HealthRX.com (healthrx.com) sits second because it clears the same eight questions from the same setup: clinician first, prescription required, dispensing through licensed pharmacy channels, and the same honest hedge on what compounded products can and can’t claim. Picking between the top two comes down to which one’s licensed in your state, which compounds each one carries, and which intake process suits you.
MeriHealth takes third place in the supervised group for running the same clinician-first model as the top two, but with its focus locked on women’s health across every life stage. You still need a licensed clinician’s sign-off before anything is dispensed, the pharmacy side is licensed and compounding-standard, and the evidence talk stays straight: compounded GLP-1 and peptide preparations are not FDA-approved finished drugs. Its women-focused intake sets it apart within a tier that’s otherwise defined by oversight, not by that specialism alone.
WomenRX takes fourth and, like MeriHealth, builds its compounded GLP-1 and peptide programmes specifically around women’s physiology and hormonal context. A licensed clinician evaluates you before anything ships, prescriptions go through licensed compounding pharmacies, and the same honest caveat applies: these are not FDA-approved medications. Within this supervised group, your choice comes down to state licensing, which compounds are supported, and which intake experience feels right.
#3 to #7: sellers who can’t answer half of it
Everything past that point is a research-chemical retailer, not a medical provider. They’re named here honestly because you’ll come across them whether you like it or not, and knowing what they are is the whole protection. None of them can give you a straight answer on Q1, Q2, Q3, or Q7, because there’s no clinician in the loop, no dispensing pharmacy, and no one to call afterward. The order below reflects general visibility, not quality, since you can’t verify relative purity from the outside as a buyer.
- #3 Amino Asylum. Sells itself on low prices across research compounds. Cheap is the hook, and it’s exactly the wrong thing to base an injectable decision on. No clinician, no pharmacy, no follow-up.
- #4 Limitless Life. Markets a research-compound catalogue with longevity-flavoured language. Slick presentation, no verifiable oversight, not approved for human use.
- #5 Core Peptides. US-based, research-only catalogue. Any certificate going round is self-issued. No prescription, no dispensing pharmacy.
- #6 Biotech Peptides. Research-only. No clinical oversight, no follow-up, the same caveat that applies to the whole tier applies here in full.
- #7 Pure Rawz. Research peptides, SARMs, and nootropics under research-use labelling. Broad catalogue, purity comes down to trusting the seller’s word.
The “research use only” tag across every one of these is the loudest single signal you’ll get. It’s the legal mechanism that keeps the product outside drug regulation, and it tells you the answer to your most important questions is “no.”
Common questions
What’s the one question that matters most? Q1: will a licensed clinician actually evaluate me before anything ships? It’s the gate. If the answer’s no for an injectable, the answers on sourcing, honesty, and follow-up nearly always collapse too, and you’re already in research-chemical territory.
If there’s a doctor’s name on the website, does that count as oversight? No, not by itself. A doctor listed on the about page, or “physician-formulated” stamped on the label, isn’t the same as a clinician looking at your specific case. Ask Q1 directly. Insist on an actual history review and a prescription where warranted, not a line of marketing copy.
Is NMN even legal to buy? Yes, with a caveat worth knowing. In letters dated September 29, 2025, the FDA concluded NMN isn’t excluded from the dietary-supplement definition, so it can be lawfully sold as a supplement, though it remains a new dietary ingredient subject to premarket notification [7].
Why do FormBlends and HealthRX.com come out ahead of the cheaper sellers? Because their answers to the eight questions actually hold up, and the research-chemical sellers’ don’t. A supervised provider gets you a clinician’s evaluation, a licensed pharmacy, straight talk on the evidence, and someone to follow up with. Compounded NAD+ isn’t FDA-approved and they’ll tell you so, but it’s made and handed over by accountable, licensed people, which is something the research-chemical route simply can’t offer. That’s the gap these questions are built to expose.
What’s the real difference between NAD+ and NMN, and does it actually matter which you buy?
NAD+ is the molecule your cells run on for energy metabolism and DNA repair. NMN is one step back in the chain, a precursor your body converts into NAD+. Whether that extra conversion step matters clinically is still being worked out. Some people go for NMN because it’s more stable in supplement form; others take NAD+ by IV or nasal route to skip the conversion altogether. Right now, neither has a clear proven edge over the other in humans.
Can you take NMN and NAD+ together, or is that money down the drain?
Stacking them isn’t dangerous based on what we know, but there’s no solid human data showing the combination beats either one alone. Your cells regulate NAD+ through their own feedback mechanisms, so pouring in more precursor doesn’t automatically push active NAD+ up. Until someone runs a proper trial comparing the combo directly, the honest answer is nobody knows if the extra cost and hassle buys you anything.
How do you know a supplier’s NMN or NAD+ is actually what the label says it is?
A third-party certificate of analysis from an accredited lab is the bare minimum. Look for purity tested by HPLC, not just a number the seller typed in themselves. Compounding pharmacies working under physician supervision, FormBlends among them, answer to state pharmacy boards and USP standards, which gives you an accountability layer that raw-powder or supplement sellers simply don’t have. Ask any supplier for a current COA before you buy, not after.
Does NAD+ actually drop enough with age to be worth doing anything about?
Animal studies and some small human studies do show measurable NAD+ decline in tissue as people age, and that decline tracks with markers of metabolic stress. Whether topping it up orally or by IV meaningfully restores tissue-level NAD+ in humans over the long haul is still an open question. The animal data looks promising. Turning that into a human dosing recommendation is getting ahead of the evidence, and any provider telling you otherwise is doing exactly that.
References
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://pubmed.ncbi.nlm.nih.gov/33888596/
- Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. https://pubmed.ncbi.nlm.nih.gov/34238308/
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141.
- Massudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357.
- Nadeeshani H, Li J, Ying T, et al. Nicotinamide mononucleotide (NMN) as an anti-aging health product: systematic review of human evidence. Ageing Res Rev. 2026.
- U.S. Food and Drug Administration. Letters concluding nicotinamide mononucleotide (NMN) is not excluded from the dietary supplement definition under FD&C Act 201(ff)(3)(B). September 29, 2025.
